Nickson Philip 4

What Happened
Nickson Philip, Chief Business & Legal Officer of Monte Rosa Therapeutics (GLUE), reported the sale of 5,845 shares on April 9, 2026. The reported weighted-average price was $17.69 per share for total proceeds of approximately $103,413. The filing lists the transaction type as an open‑market or private sale (Form 4 code S).

Key Details

• Transaction date: 2026-04-09; Form 4 filed: 2026-04-10 (timely filing).
• Shares sold: 5,845 at a weighted-average price of $17.69; total proceeds ~ $103,413.
• Price range reported in footnote: $17.6901 to $17.71 (sale executed in multiple transactions; detailed per‑price breakdown available on request per filer).
• Shares owned after the transaction: not specified in this Form 4.
• No 10b5-1 plan, tax withholding, or late filing indicated in this filing.

Context
This was a sale (not a purchase), which is often routine for insiders and does not by itself indicate company performance or insider sentiment. The filing provides a weighted average and a narrow price range, suggesting multiple small transactions on the same day.